Skip to main content
. 2017 Feb 14;83(7):1544–1555. doi: 10.1111/bcp.13238

Figure 2.

Figure 2

Results of Pearson correlation coefficients (r) (with P‐values) between adjusted reporting odds ratios and product of dissociation constants (pKd) (threshold P‐value adjusted with Bonferroni's correction = 0.0022). ABL1/2, ABL proto‐oncogene 1, nonreceptor tyrosine kinase 1/2; AMPKA1/2, protein kinase AMP‐activated catalytic subunit alpha 1/2; B‐Raf, B‐Raf proto‐oncogene, serine/threonine kinase; CSFR, colony‐stimulating factor 1 receptor; EGFR, epidermal growth factor receptor; ERK5, mitogen‐activated protein kinase 7; FGFR1/3, fibroblast growth factor receptor 1/3; FLT3, receptor‐type tyrosine protein kinase FLT3; JAK2, Janus kinase 2; KIT, mast/stem cell growth factor receptor Kit; MET, MET proto‐oncogene, receptor tyrosine kinase; PDGFR α/β, platelet‐derived growth factor receptor α/β; PDK1, 3‐phosphoinositide‐dependent protein kinase 1; r, correlation coefficient; RAF1, RAF proto‐oncogene serine/threonine‐protein kinase; VEGFR1/2, vascular endothelial growth factor receptor 1/2